InVitro International Stock Other OTC
Equities
IVRO
US4618531036
Pharmaceuticals
Financials (USD)
Sales 2022 | 854K | Sales 2023 | 793K | Capitalization | 1.3M |
---|---|---|---|---|---|
Net income 2022 | - | Net income 2023 | - | EV / Sales 2022 | 0.29 x |
Net cash position 2022 | 1.23M | Net cash position 2023 | 1.13M | EV / Sales 2023 | 0.22 x |
P/E ratio 2022 |
69.3
x | P/E ratio 2023 |
885
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 96.73% |
Managers | Title | Age | Since |
---|---|---|---|
W. Ulmer
CEO | Chief Executive Officer | - | 19-09-14 |
Cathy Richmond
DFI | Director of Finance/CFO | - | 19-09-14 |
Atul Jhalani
PSD | President | - | 19-06-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Irwin Gruverman
BRD | Director/Board Member | 89 | 20-09-22 |
Dennis Chenoweth
BRD | Director/Board Member | - | - |
W. Ulmer
CEO | Chief Executive Officer | - | 19-09-14 |
1st Jan change | Capi. | |
---|---|---|
+24.85% | 556B | |
-6.33% | 354B | |
+19.90% | 331B | |
+7.95% | 296B | |
+13.19% | 233B | |
+5.53% | 201B | |
-9.98% | 193B | |
-12.26% | 143B | |
-6.47% | 144B |